FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dora Hatzidaki

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Emmanouil Kontopodis; Nikolaos Pantazopoulos; Maria Rovithi; Nikolaos Vardakis; Ioannis Varthalitis; Vassilis Georgoulias; Stylianos Giassas; Dora Hatzidaki; Nikolaos Kentepozidis; Sofia Agelaki
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.
Zacharenia Saridaki; Lambros Vamvakas; Nikolaos Vardakis; A Voutsina; Nikolaos Androulakis; Vassilis Georgoulias; Dora Hatzidaki; E Kabouraki; Kostas Kalbakis; Dimitris Mavroudis; John Souglakos
A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial.
Giannis Mountzios; Evagelos Popis; Nikolaos Vardakis; Maria Agelidou; Christos Emmanouilidis; Dora Hatzidaki; Niki Karachaliou; Emmanouil Kontopodis; Athanasios Kotsakis; Vassilis Georgoulias
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dora Hatzidaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Emmanouil Kontopodis; Nikolaos Pantazopoulos; Maria Rovithi; Nikolaos Vardakis; Ioannis Varthalitis; Vassilis Georgoulias; Stylianos Giassas; Dora Hatzidaki; Nikolaos Kentepozidis; Sofia Agelaki
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.
Journal of chemotherapy (Florence, Italy) 2013;25(1):49-55.
2012: Zacharenia Saridaki; Lambros Vamvakas; Nikolaos Vardakis; A Voutsina; Nikolaos Androulakis; Vassilis Georgoulias; Dora Hatzidaki; E Kabouraki; Kostas Kalbakis; Dimitris Mavroudis; John Souglakos
A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial.
British journal of cancer 2012;107(12):1932-7.
2012: Giannis Mountzios; Evagelos Popis; Nikolaos Vardakis; Maria Agelidou; Christos Emmanouilidis; Dora Hatzidaki; Niki Karachaliou; Emmanouil Kontopodis; Athanasios Kotsakis; Vassilis Georgoulias
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group.
Lung cancer (Amsterdam, Netherlands) 2012;77(1):146-50.
2012: Athanasios Kotsakis; Nikolaos Vardakis; E-K Vetsika; D Aggouraki; Ch Christophyllakis; S Christou; P Cordopatis; Vassilis Georgoulias; Dora Hatzidaki; G Konsolakis; K Kosmatopoulos; Dimitris Mavroudis
Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(2):442-9.
2011: Athanasios G Pallis; Lambros Vamvakas; Nikolaos Vardakis; Vassiliki Bozionelou; Dora Hatzidaki; Antonia Kalykaki; A Karampeazis; Athanasios Kotsakis; Dimitris Mavroudis; Vassilis Georgoulias
Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(11):2448-55.
2011: Nikolaos Vardakis; Ippokratis Messaritakis; Chara Papadaki; Georgios Agoglossakis; Maria Sfakianaki; Zacharenia Saridaki; Stella Apostolaki; Ioannis Koutroubakis; Maria Perraki; Dora Hatzidaki; Dimitris Mavroudis; Vassilis Georgoulias; John Souglakos
Prognostic significance of the detection of peripheral blood CEACAM5mRNA-positive cells by real-time polymerase chain reaction in operable colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(1):165-73.
2010: Athanasios Kotsakis; Dora Hatzidaki; Lambros Vamvakas; Nikolaos Vardakis; Antonia Kalykaki; Vassiliki Bozionelou; Nikolaos Androulakis; Kostas Kalbakis; Zacharenia Saridaki; Vassilis Georgoulias; Sofia Agelaki
A retrospective analysis of non-platinum-based first- and second-line chemotherapy in patients with advanced non-small cell lung cancer.
Anticancer research 2010;30(10):4335-42.
2010: Aristea Kalikaki; ANASTASIOS KOUTSOPOULOS; Dora Hatzidaki; Maria Trypaki; Emmanouel Kontopodis; Efstathios N Stathopoulos; Dimitris Mavroudis; Vassilis Georgoulias; A Voutsina
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status.
Lung cancer (Amsterdam, Netherlands) 2010;69(1):110-5.
2010: Sofia Agelaki; Dora Hatzidaki; Athanasios Kotsakis; Pavlos Papakotoulas; Aristidis Polyzos; Nikolaos Ziras; Ioannis Gioulbasanis; Athanasios Karampeazis; Athina Agelidou; Xanthi Tsiafaki; Vassilis Chandrinos; Maria Lerikou; Vassilis Georgoulias
Non-platinum-based first-line followed by platinum-based second-line chemotherapy or the reverse sequence in patients with advanced non-small cell lung cancer: a retrospective analysis by the lung cancer group of the Hellenic Oncology Research Group.
Oncology 2010;78(3-4):229-36.
2009: Chara Papadaki; Dimitris Mavroudis; Maria Trypaki; ANASTASIOS KOUTSOPOULOS; Efstathios N Stathopoulos; Dora Hatzidaki; Eleftheria Tsakalaki; Vassilis Georgoulias; John Souglakos
Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3827-33.
2008: John Souglakos; I Boukovinas; M Taron; Pedro Méndez; Dimitris Mavroudis; M Tripaki; Dora Hatzidaki; ANASTASIOS KOUTSOPOULOS; Efstathios N Stathopoulos; Vassilis Georgoulias; R Rosell
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine.
British journal of cancer 2008;98(10):1710-5.
2008: Vassilis Georgoulias; Nikolaos Androulakis; Athanasios Kotsakis; Dora Hatzidaki; Konstantinos Syrigos; Aristidis Polyzos; Athina Agelidou; Ioannis Varthalitis; Nikolaos Ziras; Maria Agelidou; Vassilis Chandrinos; Ioannis Boukovinas; A Geroyianni; Lambros Vamvakas; Dimitris Mavroudis
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.
Lung cancer (Amsterdam, Netherlands) 2008;59(1):57-63.
2006: Dora Hatzidaki; Sofia Agelaki; Dimitris Mavroudis; Ioannis Vlachonikolis; Athanasios Alegakis; Vassilis Georgoulias
A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer.
Clinical lung cancer 2006;8(1):49-55.
2001: J Janinis; M Papadakou; G Panagos; A Panousaki; Vassilis Georgoulias; Dora Hatzidaki; Dimitris Lefantzis; George Dokianakis
Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer.
American journal of clinical oncology 2001;24(3):227-31.
2000: Dimitris Mavroudis; Charalabos Kourousis; Nikolaos Androulakis; Kostas Kalbakis; Sofia Agelaki; Stylianos Kakolyris; John Souglakos; Evanthia Sarra; Nikolaos Vardakis; Dora Hatzidaki; G Sarmonis; Vassilis Georgoulias
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
American journal of clinical oncology 2000;23(4):341-4.
2000: THEODORE GIANNAKAKIS; Nikolaos Ziras; Stylianos Kakolyris; Dimitris Mavroudis; Nikolaos Androulakis; Sofia Agelaki; M Parashos; Evanthia Sarra; T Dimou; Dora Hatzidaki; John Vlachonikolis; Vassilis Georgoulias
Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study.
European journal of cancer (Oxford, England : 1990) 2000;36(6):742-7.
2000: Charalambos Kouroussis; Sofia Agelaki; Dimitris Mavroudis; John Souglakos; Stylianos Kakolyris; Kostas Kalbakis; Nikolaos Vardakis; D Reppa; Dora Hatzidaki; George Samonis; Vassilis Georgoulias
A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2000;46(6):488-92.
1999: Stylianos Kakolyris; Charalabos Kourousis; Michael I Koukourakis; Nikolaos Androulakis; Lambros Vamvakas; Sofia Agelaki; Dora Hatzidaki; George Samonis; Dimitris D Tsiftsis; Vassilis Georgoulias
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.
American journal of clinical oncology 1999;22(6):568-72.
1999: Charalambos Kouroussis; Nikolaos Androulakis; Stylianos Kakolyris; John Souglakos; T Kotsakis; Dimitris Mavroudis; K Katsogridakis; Nikolaos Vardakis; Dora Hatzidaki; George Samonis; John Vlachonikolis; Vassilis Georgoulias
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):862-9.
1998: Nikolaos Androulakis; Charalambos Kouroussis; Stylianos Kakolyris; S Tzannes; Emmanuel Papadakis; Christos Papadimitriou; A Geroyianni; T Georgopoulou; I Dimopoulou; John Souglakos; Athanasios Kotsakis; Nikolaos Vardakis; Dora Hatzidaki; Vassilis Georgoulias
Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1127-30.
1998: Vassilis Georgoulias; Nikolaos Androulakis; Demosthenes Bouros; Charalambos Kouroussis; K Chatzakis; M Papadakis; F Apostopoloulou; T Georgopoulou; T Kotsakis; J Souklakos; Dora Hatzidaki; John Vlachonikolis; G Panagos
Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer.
Lung cancer (Amsterdam, Netherlands) 1998;21(3):213-20.
1998: Charalabos Kourousis; Stylianos Kakolyris; Nikolaos Androulakis; P Heras; J Vlachonicolis; Lambros Vamvakas; M Vlata; Dora Hatzidaki; George Samonis; Vassilis Georgoulias
Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer.
American journal of clinical oncology 1998;21(3):226-32.
1998: Vassilis Georgoulias; Nikolaos Androulakis; Athanassios Meletios Dimopoulos; Charalabos Kourousis; Stylianos Kakolyris; Emmanuel Papadakis; F Apostolopoulou; Christos Papadimitriou; Andreas Vossos; Maria Agelidou; P Heras; S Tzannes; J Vlachonicolis; E Mavromanolakis; Dora Hatzidaki
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):331-4.
1997: Vassilis Georgoulias; Charalabos Kourousis; Nikolaos Androulakis; Stylianos Kakolyris; Meletios A Dimopoulos; Demosthenes Bouros; Christos Papadimitriou; Kostas D Hatzakis; P Heras; Kostas Kalbakis; T Kotsakis; Nikolaos Vardakis; N Meramveliotakis; Dora Hatzidaki
Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.
Seminars in oncology 1997;24(4 Suppl 14):S14-22-S14-25.
1997: Vassilis Georgoulias; Charalabos Kourousis; Nikolaos Androulakis; Stylianos Kakolyris; Emmanuel Papadakis; Demosthenes Bouros; F Apostolopoulou; T Georgopoulou; Maria Agelidou; John Souglakos; george chalkiadakis; Dora Hatzidaki
Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 14):S14-9-S14-14.
1997: Vassilis Georgoulias; Charalabos Kourousis; Stylianos Kakolyris; Nikolaos Androulakis; Meletios A Dimopoulos; Emmanuel Papadakis; T Kotsakis; Nikolaos Vardakis; Kostas Kalbakis; N Merambeliotakis; Dora Hatzidaki
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimen.
Seminars in oncology 1997;24(4 Suppl 12):S12-61-S12-66.